Studies have shown that ACE inhibitors and ARBs may have a protective effect on the liver by inhibiting the angiotensin-aldosterone system, reducing oxidative stress, and improving blood flow, which may help to slow the process of liver fibrosis [28,29]. Here, ACE is linked to Hepatic fibrosis.